Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23,900 | 11 | 67.2% |
| Travel and Lodging | $9,604 | 14 | 27.0% |
| Food and Beverage | $2,040 | 44 | 5.7% |
| Education | $18.00 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $22,272 | 41 | $0 (2020) |
| Allergan Inc. | $13,052 | 23 | $0 (2017) |
| Amgen Inc. | $115.47 | 1 | $0 (2018) |
| Ferring Pharmaceuticals Inc. | $65.72 | 3 | $0 (2024) |
| Organon Llc | $32.10 | 1 | $0 (2024) |
| Medtronic, Inc. | $12.84 | 1 | $0 (2023) |
| Myovant Sciences Inc. | $12.21 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $80.28 | 3 | Ferring Pharmaceuticals Inc. ($48.18) |
| 2023 | $12.84 | 1 | Medtronic, Inc. ($12.84) |
| 2022 | $12.21 | 1 | Myovant Sciences Inc. ($12.21) |
| 2020 | $1,765 | 2 | AbbVie Inc. ($1,765) |
| 2019 | $12,651 | 22 | AbbVie, Inc. ($12,634) |
| 2018 | $7,989 | 19 | AbbVie, Inc. ($7,874) |
| 2017 | $13,052 | 23 | Allergan Inc. ($13,052) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Organon Llc | FOLLISTIM AQ (Drug), GANIRELIX ACETATE, FOLLISTIM AQ | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: FOLLITROPIN | ||||||
| 09/24/2024 | Ferring Pharmaceuticals Inc. | MENOPUR (Biological) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: REPRODUCTIVE HEALTH | ||||||
| 06/13/2024 | Ferring Pharmaceuticals Inc. | MENOPUR (Biological) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: REPRODUCTIVE HEALTH | ||||||
| 04/04/2023 | Medtronic, Inc. | VALLEYLAB FT10 (Device) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Electrosurgical Products | ||||||
| 05/12/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: HORMONE THERAPY | ||||||
| 03/04/2020 | AbbVie Inc. | ORILISSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: WOMENS HEALTH | ||||||
| 02/28/2020 | AbbVie Inc. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: WOMENS HEALTH | ||||||
| 11/12/2019 | AbbVie, Inc. | Orilissa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: Endocrinology | ||||||
| 11/07/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Endocrinology | ||||||
| 10/15/2019 | AbbVie, Inc. | Orilissa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: Endocrinology | ||||||
| 10/10/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Endocrinology | ||||||
| 10/01/2019 | Ferring Pharmaceuticals Inc. | MENOPUR (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: REPRODUCTIVE HEALTH | ||||||
| 06/26/2019 | AbbVie, Inc. | Orilissa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: Endocrinology | ||||||
| 06/20/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Endocrinology | ||||||
| 05/13/2019 | AbbVie, Inc. | Orilissa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: Endocrinology | ||||||
| 05/07/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $102.07 | General |
| Category: Endocrinology | ||||||
| 04/25/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $204.48 | General |
| Category: Endocrinology | ||||||
| 04/09/2019 | AbbVie, Inc. | Orilissa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Endocrinology | ||||||
| 03/29/2019 | AbbVie, Inc. | Orilissa (Drug) | Travel and Lodging | In-kind items and services | $1,716.76 | General |
| Category: Endocrinology | ||||||
| 03/29/2019 | AbbVie, Inc. | Orilissa (Drug) | Travel and Lodging | In-kind items and services | $260.44 | General |
| Category: Endocrinology | ||||||
| 03/29/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $67.50 | General |
| Category: Endocrinology | ||||||
| 03/29/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $66.15 | General |
| Category: Endocrinology | ||||||
| 03/29/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Endocrinology | ||||||
| 03/29/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Endocrinology | ||||||
| 03/29/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Endocrinology | ||||||
About Dr. Gary Levy, MD
Dr. Gary Levy, MD is a Reproductive Endocrinology healthcare provider based in Tripler Army Medical Center, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2013. The National Provider Identifier (NPI) number assigned to this provider is 1750725206.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Levy, MD has received a total of $35,562 in payments from pharmaceutical and medical device companies, with $80.28 received in 2024. These payments were reported across 71 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($23,900).
Practice Information
- Specialty Reproductive Endocrinology
- Other Specialties Reproductive Endocrinology
- Location Tripler Army Medical Center, HI
- Active Since 04/25/2013
- Last Updated 09/09/2021
- Taxonomy Code 207VE0102X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750725206
Products in Payments
- Orilissa (Drug) $16,767
- Lupron (Drug) $3,722
- ORILISSA (Drug) $1,765
- Repatha (Biological) $115.47
- MENOPUR (Biological) $48.18
- FOLLISTIM AQ (Drug) $32.10
- MENOPUR (Drug) $17.54
- VALLEYLAB FT10 (Device) $12.84
- MYFEMBREE (Drug) $12.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.